Zelgen Biopharmaceuticals’ Donafenib Receives NMPA Approval for Thyroid Cancer
China-based Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266) announced that the supplementary New Drug Application...
Siemens Healthineers Q3 2022 Results Show Decline Amid COVID-19 Impact
Siemens Healthineers AG (ETR: SHL) released its financial results for the fiscal year Q3 2022...
Chinese Researchers Map Cancer Genomic Alterations in 10,000 Patients
A team of Chinese researchers led by Wang Minghui at Sun Yat-sen University has conducted...
Longwood Valley Medtech Partners with J&J MedTech on Digital Surgery Biosystem
Beijing-based Longwood Valley Medtech has entered into an in-depth partnership with US major Johnson &...
Elite Pharma Raises RMB100m in Series B Financing for Drug Delivery Tech
Shanghai-based Elite Pharmaceutical Technology Inc. has reportedly raised nearly RMB100 million (USD14.8 million) in a...
WuXi ATU Licenses TESSA Technology to Janssen Biotech for AAV Production
WuXi Advanced Therapies (WuXi ATU), the gene and cell therapy-focused CTDMO unit of WuXi Apptec,...
Medlander Medical Technology’s IPO Raises RMB 1 billion on Shanghai’s STAR Board
Medlander Medical Technology Inc., a leading Chinese manufacturer of pelvic floor rehabilitation equipment, has completed...
InnoCare Pharma’s Orelabrutinib sNDA Accepted for Marginal Zone Lymphoma
InnoCare Pharma (HKG: 9969) announced that a supplemental New Drug Application (sNDA) for its Bruton’s...
TianShiWei Raises Tens of Millions in Series A for Medical Aesthetics Expansion
hina-based Wuhan TianShiWei Biotechnology Co., Ltd has reportedly raised tens of millions of renminbi in...
BeiGene Partners with Jilin Cancer Hospital for Cancer Drug Development
China-based BeiGene (NASDAQ: BGNE, HKG: 6160, SHA: 688235) has entered into a clinical study partnership...
China Ramps Up Monitoring of Clinically Shortage Drugs Involving 109 Varieties
The Ministry of Industry and Information Technology (MIIT), National Health Commission (NHC), National Healthcare Security...
Arbele’s ARB202 Enters Phase I Trial for Advanced Gastrointestinal Cancer
Hong Kong-based biopharma Arbele announced that its CDH17 × CD3 bispecific T-Cell engager antibody, ARB202,...
ByteDance Acquires Amcare Healthcare for USD1.5b via Xiaohe Health Unit
ByteDance Ltd, the parent company of social media platforms TikTok and Douyin, has acquired Amcare...
Taihu Bay Healthcare Conference Launches Wuxi IP Protection Center
The 2022 Taihu Bay Future Healthcare Conference was held in Wuxi City, Jiangsu province, China,...
United Imaging Healthcare’s STAR Listing Raises USD1.85 Billion
Shanghai-based United Imaging Healthcare (UIH) has completed an initial public offering (IPO) of 100 million...
Boston Scientific’s Rezūm System Installed in China’s Urinary Innovation Center
US major Boston Scientific Corporation (NYSE: BSX) has jointly established the “Urinary Joint Innovation Center”...
Trautec Medical Raises RMB200m in Series A Financing for Recombinant Collagen R&D
China-based Jiangsu Trautec Medical Technology Co., Ltd. has reportedly raised nearly RMB200 million (USD205.3 million)...
Zhaoke Ophthalmology Enrolls First Patient in ZKY001 Phase II TPRK Study
China-based Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) spin-off Zhaoke Ophthalmology Ltd (HKG: 6622) announced the...
Insilico Medicine Closes USD95m Series D Financing to Advance AI Drug Discovery
Insilico Medicine, a Hong Kong-based artificial intelligence (AI)-driven drug discovery company, announced the closure of...
LianBio Completes Enrollment for Mavacamten Phase III Trial in oHCM
China-based biotech LianBio (OTCMKTS: LIANY) announced that enrollment has been completed in the Phase III...